Verification evidence is still being completed.
PDF / print export
ArcDia International
Turku, Finland
- Verified lead
- Janne Koskinen
- Lead status
- STATUS: VERIFIED MARCH 2026
- Leadership verification
- CEO and CSO
- 2026 technical specialization
- In-Vitro Diagnostics, Infectious Disease Testing, Automated IVD Systems, and Near-Patient Diagnostics
- Review cycle
- May 2026
- Full address
- Tykistokatu 4 B, 20520 Turku, Finland
- Site coordinates
- Verification evidence is still being completed.
- Editorial review
- Memel Biotech editorial review
- Official leadership source
- Official ArcDia contact page confirming the Turku operating address.
- Editorial note
- ArcDia is published because the official site confirms current leadership, Turku operating footprint, and a real IVD platform centered on automated infectious-disease testing.
In-Vitro Diagnostics, Infectious Disease Testing, Automated IVD Systems, and Near-Patient Diagnostics
Official personnel disclosure, Official Turku contact disclosure, Automated IVD platform claim
ArcDia is published because the official site confirms current leadership, Turku operating footprint, and a real IVD platform centered on automated infectious-disease testing.
Review coverage
Leadership
Facility
Certifications
Capabilities
Partners
Sources
Quality
Editorial verificationMemel Biotech directory review sign-off
Report generated02 Jun 2026, 01:40
Company profile · Turku, Finland
ArcDia International
In-Vitro Diagnostics, Infectious Disease Testing, Automated IVD Systems, and Near-Patient Diagnostics · Commercial diagnostics platform
ArcDia International runs automated ivd platform development, infectious disease diagnostics, and near-patient testing systems in Turku, Finland.
- Lead
- Janne Koskinen (verified ↗)
- Address
- Tykistokatu 4 B, 20520 Turku, Finland (source ↗)
- Compliance
- Not yet on record
- Last reviewed
- 21 Mar 2026 (2mo ago)
- Scale
- Commercial diagnostics platform
- Capabilities
- Automated IVD Platform Development · Infectious Disease Diagnostics · Near-Patient Testing Systems
- Founded
- 2002
- Headcount
- 11-50
- Company page (open ↗)
Clinical profileSTATUS: VERIFIED MARCH 2026
Janne Koskinen
CEO and CSO
Full addressTykistokatu 4 B, 20520 Turku, Finland
Site coordinatesVerification evidence is still being completed.
Review cycleMay 2026
Physical site source
Official ArcDia contact page listing the Tykistokatu 4 B Turku address.
Open sourceCommercial diagnostics platform
Turku, Finland. In-Vitro Diagnostics, Infectious Disease Testing, Automated IVD Systems, and Near-Patient Diagnostics. Review completed on 21 Mar 2026.
Finnish diagnostics and medical-device operating oversight
Official personnel disclosure, Official Turku contact disclosure, Automated IVD platform claim
In-Vitro Diagnostics, Infectious Disease Testing, Automated IVD Systems, and Near-Patient Diagnostics
ArcDia is published because the official site confirms current leadership, Turku operating footprint, and a real IVD platform centered on automated infectious-disease testing.
Editorial note
ArcDia is published because the official site confirms current leadership, Turku operating footprint, and a real IVD platform centered on automated infectious-disease testing.
FULL TRUST REVIEW COMPLETE
Shown only when all seven trust checks are fully mapped in the directory.
Current review cycleMarch 2026
Capabilities
Core capabilities
Primary declared technical activities and areas of operating focus.
Automated IVD Platform Development
Infectious Disease Diagnostics
Near-Patient Testing Systems
Verification source dossier
Verification source dossier
Official source set used to support leadership, physical-site, certification, and watch-note evidence.
Infrastructure
Declared infrastructure
mariPOC diagnostics platform
Automated infectious-disease testing workflow
IVD development infrastructure
Regulatory posture
Quality system coverage
GMP / GLP / ISO-13485 / FDA-Inspected are global quality-system standards. "Verified active" means the directory confirmed the certification is current; "Review in progress" means the cert status is currently being re-verified.
- GMP
- REVIEW IN PROGRESS 2026
- GLP
- REVIEW IN PROGRESS 2026
- ISO-13485
- REVIEW IN PROGRESS 2026
- FDA-Inspected
- REVIEW IN PROGRESS 2026
Verification history
Verification history
21 Mar 2026: Executive identity confirmed via official management disclosure.
21 Mar 2026: Full trust review completed.
FAQ
Frequently asked questions
- Where is ArcDia International located?
- ArcDia International operates from Tykistokatu 4 B, 20520 Turku, Finland, Turku, Finland.
- Who runs ArcDia International?
- ArcDia International is led by Janne Koskinen, CEO and CSO. Verified 21 Mar 2026.
- What does ArcDia International do?
- ArcDia International runs automated ivd platform development, infectious disease diagnostics, and near-patient testing systems in Turku, Finland. Core capabilities: Automated IVD Platform Development, Infectious Disease Diagnostics, Near-Patient Testing Systems.
Editorial context
Related technical briefs
Briefs that name Turku as a covered market or city.